Search Results - "Ciolek, Alana M."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Eptacog Beta for Bleeding Treatment and Prevention in Congenital Hemophilia A and B With Inhibitors: A Review of Clinical Data and Implications for Clinical Practice by Ciolek, Alana M., Arnall, Justin, Moore, Donald C., Palkimas, Surabhi, Der-Nigoghossian, Julie, Dane, Kathryn

    Published in Annals of Pharmacotherapy (01-07-2022)
    “…Objective: To review the pharmacology, dosing and administration, safety, clinical efficacy, and role of eptacog beta in the treatment of congenital hemophilia…”
    Get full text
    Book Review Journal Article
  2. 2

    674-P: Glycemic Management Practice Guideline Combined with a Multidisciplinary Champion Team Approach Increased the Use of Basal Bolus Insulin Regimen and Reduced the Use of Sliding Scale Insulin by BOGUN, MAGDALENA M., ZAGOREN, ELEANOR, ACKERMAN, KEVIN, CIOLEK, ALANA M.

    Published in Diabetes (New York, N.Y.) (01-06-2019)
    “…Basal-bolus insulin (BBI) therapy is recommended for treatment of hyperglycemia in the inpatient setting, but many patients still receive sliding scale insulin…”
    Get full text
    Journal Article
  3. 3

    A reappraisal of the pharmacologic management of gastrointestinal bleeding in patients with continuous flow left ventricular assist devices by Littlefield, Audrey J., Jones, Gregory, Ciolek, Alana M., Yuzefpolskaya, Melana, Jennings, Douglas L.

    Published in Heart failure reviews (01-03-2021)
    “…Advancements in the design and functionality of continuous flow left ventricular assist devices (CF-LVADs), as well as a limited number of donor hearts, have…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Engineering a Brighter Future: The Evolving Role of the Pharmacist in the Era of the HeartMate 3 by Ciolek, Alana M., Littlefield, Audrey J., Jennings, Douglas L.

    Published in The Annals of pharmacotherapy (01-04-2019)
    “…Continuous-flow left-ventricular assist devices (CF-LVADs) are an option for patients with end-stage heart failure requiring durable mechanical circulatory…”
    Get full text
    Journal Article
  6. 6

    Impact of heart failure drug therapy on rates of gastrointestinal bleeding in LVAD recipients: An INTERMACS analysis by Jennings, Douglas L, Truby, Lauren K, Littlefield, Audrey J, Ciolek, Alana M, Marshall, Dylan, Jain, Rashmi, Topkara, Veli K

    Published in International journal of artificial organs (01-12-2021)
    “…Introduction: Gastrointestinal bleeding (GIB) remains a common and vexing complication of left ventricular assist device (LVAD) support. Recent single-center…”
    Get full text
    Journal Article